No Licence Renewal For Blood Centres Sans Hospital

Dehradun: All blood centres operating outside of hospitals in Uttarakhand will no longer be eligible for licence renewal, a circular issued on Saturday by the Uttarakhand Food and Drug Authority (FDA) said.

Currently, 82 blood centres are operational in the state, and this directive is expected to impact 30-35 of them, a source in the department said. However, centres run by organisations like Indian Medical Association (IMA) or those under Red Cross will not be affected, as they are classified as charity organisations, according to officials.

Existing centres with a five-year licence will not have to establish a hospital, but once the licences expire, they will not be renewed unless they have moved into hospital premises.

Tajber Singh, additional commissioner, state Food and Drug Administration, said, “Affiliation with any hospital won’t help. Blood centres must be within hospital premises, to ensure that patients in need of blood and plasma receive priority. It also promotes strict preservation of blood as per protocols.”

The move is expected to curb high prices charged by private blood banks during crises and to address issues of incorrect blood transfusions by promoting proper testing and storage of blood.

Related Posts

  • Pharma
  • July 26, 2024
  • 128 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 125 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD